Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance-Reference-Cited by-同舟云学术

Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance

Published:2020-07-09 Issue:9 Volume:17 Page:3270-3280
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zhu Chune¹²,Chen Jianting²,Yu Shihui²,Que Chailu²,Taylor Lynne S.²^ORCID,Tan Wen³,Wu Chuanbin⁴,Zhou Qi Tony²^ORCID

Affiliation:

1. School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, 280 Waihuan East Road, Guangzhou 510006, China

2. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana 47907, United States

3. Institute for Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuan West Road, Guangzhou 510006, China

4. School of Pharmaceutical Sciences, Sun Yat-Sen University, 132 Waihuan East Road, Guangzhou 510006, China

Funder

National Institute of Allergy and Infectious Diseases

Natural Science Foundation of Guangdong Province

School of Traditional Chinese Medicine, Guangdong Pharmaceutical University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00390

Reference57 articles.

1. Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers

2. Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis

3. Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1

4. The role of microRNAs in chronic pseudomonas lung infection in Cystic fibrosis

5. Synthesis and characterization of a photoaffinity labelling probe based on the structure of the cystic fibrosis drug ivacaftor

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges;Journal of Drug Delivery Science and Technology;2024-06

2. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives;Pharmaceutics;2024-03-01

3. Preparation and in vitro characterization of clofazimine-loaded albumin nanocomposite microparticles for inhalation therapy;Journal of Drug Delivery Science and Technology;2024-03

4. Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice;International Journal of Pharmaceutics;2024-01

5. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component;Molecular Pharmaceutics;2023-11-09